These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 108343)

  • 21. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa.
    Berk RS; Hazlett LD
    Rev Infect Dis; 1983; 5 Suppl 5():S936-40. PubMed ID: 6658287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.
    Serra R; Grande R; Butrico L; Rossi A; Settimio UF; Caroleo B; Amato B; Gallelli L; de Franciscis S
    Expert Rev Anti Infect Ther; 2015 May; 13(5):605-13. PubMed ID: 25746414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The host genetic background defines diverse immune-reactivity and susceptibility to chronic Pseudomonas aeruginosa respiratory infection.
    Spagnuolo L; De Simone M; Lorè NI; De Fino I; Basso V; Mondino A; Cigana C; Bragonzi A
    Sci Rep; 2016 Nov; 6():36924. PubMed ID: 27848994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with Bivalent Flagellin Protects Mice against Fatal
    Behrouz B; Hashemi FB; Fatemi MJ; Naghavi S; Irajian G; Halabian R; Imani Fooladi AA
    J Immunol Res; 2017; 2017():5689709. PubMed ID: 29201922
    [No Abstract]   [Full Text] [Related]  

  • 28. Amphotericin B-induced resistance to Pseudomonas aeruginosa infection in mice.
    Matsumoto T; Kaku M; Furuya N; Usui T; Kohno S; Tomono K; Tateda K; Hirakata Y; Yamaguchi K
    J Antibiot (Tokyo); 1993 May; 46(5):777-84. PubMed ID: 8514633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse footpad infection by Pseudomonas aeruginosa: evidence for delayed hypersensitivity to specific bacterial antigen.
    Garzelli C; Colizzi V; Campa M; Falcone G
    Med Microbiol Immunol; 1980; 168(2):111-8. PubMed ID: 6779101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The structure of populations of Pseudomonas aeruginosa in association with staphylococci and Escherichia].
    Bel'skiĭ VV; Shatalova EV; Singh PK
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):37-8. PubMed ID: 7879525
    [No Abstract]   [Full Text] [Related]  

  • 32. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.
    Powderly WG; Pier GB; Markham RB
    J Clin Invest; 1986 Aug; 78(2):375-80. PubMed ID: 2426306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological comparisons of Staphylococcus aureus and Pseudomonas aeruginosa experimental infected porcine burn wounds.
    Chaney SB; Ganesh K; Mathew-Steiner S; Stromberg P; Roy S; Sen CK; Wozniak DJ
    Wound Repair Regen; 2017 May; 25(3):541-549. PubMed ID: 28466497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of staphylococci-induced delayed-type hypersensitivity and nonspecific resistance during their development, long-term duration and adoptive transfer.
    Shayegani M; Parsons LM; Maupin PS
    J Reticuloendothel Soc; 1980 Sep; 28(3):265-74. PubMed ID: 6997485
    [No Abstract]   [Full Text] [Related]  

  • 36. Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1983 Mar; 39(3):1067-71. PubMed ID: 6404816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa infection and vaccination in the rat.
    Kostiala AA
    J Med Microbiol; 1980 May; 13(2):201-12. PubMed ID: 6770090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies on bacterial product cantastim derived from Pseudomonas aeruginosa. VI. Protection in tolerant mice.
    Caraş I; Sălăgeanu A
    Roum Arch Microbiol Immunol; 2004; 63(1-2):47-62. PubMed ID: 16295320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-modulatory functions of the type-3 secretion system and impacts on the pulmonary host defense: A role for ExoS of Pseudomonas aeruginosa in cystic fibrosis.
    Belmadi N; Wu Y; Touqui L
    Toxicon; 2018 Mar; 143():68-73. PubMed ID: 29339019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.